OncoSil Medical (ASX:OSL) has announced the appointment of Shelley Steyn as chief financial officer, effective 5 May.
Latest News
New Stories
-
OncoSil Medical appoints as chief financial officer
March 18, 2025 - - Latest News -
Nyrada commences recruitment for phase one clinical trial
March 18, 2025 - - Latest News -
Neurizon Therapeutics updates investors on initiatives to lift clinical hold
March 18, 2025 - - Latest News -
Race secures ethics approval for RC220 Phase 1 solid tumour trial
March 18, 2025 - - Latest News -
Radiopharm Theranostics says new data confirms positive tumour uptake
March 18, 2025 - - Latest News -
Telix completes the acquisition of FAP-targeting theranostic candidates
March 13, 2025 - - Latest News -
Argent BioPharma signs exclusive agreement for Malta manufacturing facility
March 13, 2025 - - Latest News